-
FDA Votes In Favor Of Removing Side-Effect Warning On Pfizer's Chantix
Thursday, September 15, 2016 - 8:57am | 444Read More...Pfizer Inc. (NYSE: PFE)'s Chantix is a prescription medication that helps adults 18 years and older quit smoking. The drug has been linked with reports of mental health problems, risk of suicide, depression and death in users, which prompted the U.S. Food and Drug Administration (FDA) to issue...
-
Citigroup Releases Pfizer Core Product Trends; Explains Price Target
Tuesday, October 26, 2010 - 7:41am | 143Read More...Citigroup has released its Pfizer, Inc. (NYSE: PFE) core product trends for the week ending 10/15/2010. Lipitor, Lyrica, Chantix and AriceptXR are among the drugs featured in the report. “We arrive at our $17 target price for Pfizer based on a relative P/E compared to the US Drug peer group,”...
-
Pfizer's Product Trends For The Week Ending 9/24
Wednesday, October 6, 2010 - 7:41am | 348Read More...Citigroup has issued a report on Pfizer's (NYSE: PFE) product trends for the week ending on 9/24. In the report, Citigroup writes "Lipitor NRx/TRx Share Was 21.5%(-5bps)/22.0%(-15bps). Lipitor YOY TRx's have declined -12% YTD. PFE took 5% & 6.9% price increases(PI's) on 7/1/10 & 1/1/10...
